Stock market week-in-review for 5 large GI companies — Oct. 16-20

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Oct. 16 to Oct. 20, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $204.51 on Oct. 16
Peaked: $206.75 on Oct. 16
Closed: $188.19 on Oct. 20
Percent change between Oct. 16 and Oct. 20: -7.98 percent

2. Exact Sciences Corp.

Opened: $47.41 on Oct. 16
Peaked: $49.34 on Oct. 20
Closed: $49.15 on Oct. 20
Percent change between Oct. 16 and Oct. 20: 3.67 percent

3. Johnson & Johnson

Opened: $136.90 on Oct. 16
Peaked: $143.57 on Oct. 20
Closed: $142.38 on Oct. 20
Percent change between Oct. 16 and Oct. 20: 4 percent

4. Synergy Pharmaceuticals

Opened: $3.09 on Oct. 16
Peaked: $3.23 on Oct. 16
Closed: $2.81 on Oct. 20
Percent change between Oct. 16 and Oct. 20: -9.06 percent

5. Valeant Pharmaceuticals

Opened: $13.38 on Oct. 16
Peaked: $13.42 on Oct. 16
Closed: $12.16 on Oct. 20
Percent change between Oct. 16 and Oct. 20: -9.11 percent

More articles on gastroenterology: 
GI leader to know: Dr. Kenneth Brown
4 insights on NASH from the physicians fighting it
DIY bowel prep leaves GI physicians concerned — 7 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months